DUBLIN, Ohio, July 16, 2019 /PRNewswire/ -- Cardinal
Health (NYSE:CAH) today announced that Stephen Mason, President of the company's
Cardinal Health at-Home Solutions business, has been promoted to
Chief Executive Officer of Cardinal Health's Medical segment. Mr.
Mason will succeed Jon Giacomin, who
will be departing the company in mid-August to assume a CEO
position at a privately-held company.
Mr. Mason is a highly accomplished 20-year veteran of Cardinal
Health and has successfully led several businesses within both
Cardinal Health's Medical and Pharmaceutical segments.
Since 2016, Mr. Mason has overseen Cardinal Health at-Home
Solutions, a component of the Medical segment that has delivered
strong and consistent growth. Prior to that, he led Cardinal
Health's Kinray pharmaceutical distribution business. Mr. Mason
also has deep experience leading sales, sales operations, and
sourcing teams within the company's Pharmaceutical Distribution
business, including the Consumer Health, Sales Administration,
Retail Independent Sales and Retail National Accounts teams.
Mike Kaufmann, CEO of Cardinal
Health, commented, "We are pleased to name Steve Mason as the new CEO of our Medical
segment. He is a proven leader who has consistently generated
positive results in every business he has led within the company.
With Steve at the helm, we look forward to building on the steady
progress underway in the Medical segment as we continue to execute
on our strategy to generate improved performance and long-term
growth.
"We want to thank Jon Giacomin
for his many contributions to Cardinal Health over the years and
wish him well," concluded Mr. Kaufmann.
Mr. Mason added, "I am excited to take on responsibility for our
Medical segment and to work with our talented team of leaders to
continue to position our Medical businesses to best serve our
customers and the healthcare community while, very importantly,
meeting our long-term growth and profitability objectives. I am
confident in the plans we have in place to deliver on our
strategy."
Separately, Cardinal Health today affirmed that it expects to
meet at least the midpoint of its non-GAAP EPS guidance range for
fiscal year 2019, which was reported in its May 9, 2019 earnings release. As announced, the
company will report its financial results for its fiscal fourth
quarter and year-end, as well as its outlook for fiscal 2020, on
August 8, 2019, prior to market
open.
About Cardinal Health
Cardinal Health, Inc. is a
global, integrated healthcare services and products company,
providing customized solutions for hospitals, healthcare systems,
pharmacies, ambulatory surgery centers, clinical laboratories and
physician offices worldwide. The company enhances supply chain
efficiency for clinically proven medical products, pharmaceuticals
and cost-effective solutions. To combat prescription drug misuse,
the Cardinal Health Foundation and its education partners created
Generation Rx, a national drug prevention education and
awareness program. The Foundation actively supports an array of
other solutions, including efforts to reduce opioid
prescribing, promote drug take back and safe disposal and
expand collaborative community work. Cardinal Health is backed by
nearly 100 years of experience with operations in nearly 46
countries. For more information, visit cardinalhealth.com. Follow
us on Twitter, Facebook and LinkedIn.
Cautions Concerning Forward-Looking Statements
This
release contains forward-looking statements addressing
expectations, prospects, estimates and other matters that are
dependent upon future events or developments. These statements may
be identified by words such as "expect," "anticipate," "intend,"
"plan," "believe," "will," "should," "could," "would," "project,"
"continue," "likely," and similar expressions, and include
statements reflecting future results or guidance, statements of
outlook and various accruals and estimates. These matters are
subject to risks and uncertainties that could cause actual results
to differ materially from those projected, anticipated or implied.
For a list of these risks and uncertainties, please refer to
Cardinal Health's Form 10-K, Form 10-Q and Form 8-K reports and
exhibits to those reports. This release reflects management's views
as of July 16, 2019. Except to the
extent required by applicable law, Cardinal Health undertakes no
obligation to update or revise any forward-looking statement.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/cardinal-health-appoints-stephen-mason-to-lead-medical-segment-300885303.html
SOURCE Cardinal Health